Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Igmesine for use in the treatment of neurodegenerative diseases

Igmesine for use in the treatment of neurodegenerative diseases

US Patent 11129801 · Granted Sep 28, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for screening Icrac modulators2004
Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgi2002
2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors2000
2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors1998
Use of fedotozine in the treatment of functional states of intestinal obstructio1994
Cycloalkylalkylamines which are sigma-receptor ligands and their application in 1994
Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propy 1993
Benzodiazepines and applications in therapeutic practice1992
Substituted ethylamines, their preparation process, their use as medicine and th1991
Benzodiazepines, process and intermediates for the preparation thereof and their1990